Serological Evidence for Non-Lethal Exposures of Mongolian Wild Birds to Highly Pathogenic Avian Influenza H5N1 Virus

被引:15
|
作者
Gilbert, Martin [1 ,2 ]
Koel, Bjorn F. [3 ]
Bestebroer, Theo M. [3 ]
Lewis, Nicola S. [4 ]
Smith, Derek J. [4 ]
Fouchier, Ron A. M. [3 ]
机构
[1] Wildlife Conservat Soc, 2300 Southern Blvd, Bronx, NY 10460 USA
[2] Univ Glasgow, Coll Med Vet & Life Sci, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow G12 8QQ, Lanark, Scotland
[3] Erasmus MC, Dept Virosci, NL-3015 GE Rotterdam, Netherlands
[4] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England
来源
PLOS ONE | 2014年 / 9卷 / 12期
基金
美国国家卫生研究院; 英国生物技术与生命科学研究理事会;
关键词
A VIRUSES; EXPERIMENTAL-INFECTION; MIGRATORY WATERFOWL; GENETIC EVOLUTION; NORTHERN EUROPE; ASIAN LINEAGE; HONG-KONG; ANTIBODIES; GEESE; DUCKS;
D O I
10.1371/journal.pone.0113569
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Surveillance for highly pathogenic avian influenza viruses (HPAIV) in wild birds is logistically demanding due to the very low rates of virus detection. Serological approaches may be more cost effective as they require smaller sample sizes to identify exposed populations. We hypothesized that antigenic differences between classical Eurasian H5 subtype viruses (which have low pathogenicity in chickens) and H5N1 viruses of the Goose/Guangdong/96 H5 lineage (which are HPAIV) may be used to differentiate populations where HPAIVs have been circulating, from those where they have not. To test this we performed hemagglutination inhibition assays to compare the reactivity of serum samples from wild birds in Mongolia (where HPAIV has been circulating, n= 1,832)and Europe (where HPAIV has been rare or absent, n=497) to a panel of reference viruses including classical Eurasian H5 (of low pathogenicity), and five HPAIV H5N1 antigens of the Asian lineage A/Goose/Guangdong/1/96. Antibody titres were detected against at least one of the test antigens for 182 Mongolian serum samples (total seroprevalence of 0.10, n=1,832, 95% adjusted Wald confidence limits of 0.09-0.11) and 25 of the European sera tested (total seroprevalence of 0.05, n=497, 95% adjusted Wald confidence limits of 0.03-0.07). A bias in antibody titres to HPAIV antigens was found in the Mongolian sample set (22/182) that was absent in the European sera (0/25). Although the interpretation of serological data from wild birds is complicated by the possibility of exposure to multiple strains, and variability in the timing of exposure, these findings suggest that a proportion of the Mongolian population had survived exposure to HPAIV, and that serological assays may enhance the targeting of traditional HPAIV surveillance toward populations where isolation of HPAIV is more likely.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] New Avian Influenza Virus (H5N1) in Wild Birds, Qinghai, China
    Li, Yanbing
    Liu, Liling
    Zhang, Yi
    Duan, Zhenhua
    Tian, Guobin
    Zeng, Xianying
    Shi, Jianzhong
    Zhang, Licheng
    Chen, Hualan
    EMERGING INFECTIOUS DISEASES, 2011, 17 (02) : 265 - 267
  • [32] New Outbreaks of H5N1 Highly Pathogenic Avian Influenza in Domestic Poultry and Wild Birds in Cambodia in 2011
    Theary, Ren
    San, Sorn
    Davun, Holl
    Allal, Lotfi
    Lu, Huaguang
    AVIAN DISEASES, 2012, 56 (04) : 861 - 864
  • [33] An influenza mRNA vaccine protects ferrets from lethal infection with highly pathogenic avian influenza A(H5N1) virus
    Hatta, Masato
    Hatta, Yasuko
    Choi, Angela
    Hossain, Jaber
    Feng, Chenchen
    Keller, Matthew W.
    Ritter, Jana M.
    Huang, Ying
    Fang, Emma
    Pusch, Elizabeth A.
    Rowe, Thomas
    de la Cruz, Juan A.
    Johnson, Monique C.
    Liddell, Jimma
    Jiang, Nannan
    Stadlbauer, Daniel
    Liu, Li
    Bhattacharjee, Arindam K.
    Rouse, Joseph R.
    Currier, Michael
    Wang, Li
    Levine, Min Z.
    Kirby, Marie K.
    Steel, John
    Di, Han
    Barnes, John R.
    Henry, Carole
    Davis, C. Todd
    Nachbagauer, Raffael
    Wentworth, David E.
    Zhou, Bin
    SCIENCE TRANSLATIONAL MEDICINE, 2024, 16 (778)
  • [34] Serological evidence of human infections with highly pathogenic avian influenza A(H5N1) virus: a systematic review and meta-analysis
    Xinhua Chen
    Wei Wang
    Yan Wang
    Shengjie Lai
    Juan Yang
    Benjamin J. Cowling
    Peter W. Horby
    Timothy M. Uyeki
    Hongjie Yu
    BMC Medicine, 18
  • [35] Serological evidence of human infections with highly pathogenic avian influenza A(H5N1) virus: a systematic review and meta-analysis
    Chen, Xinhua
    Wang, Wei
    Wang, Yan
    Lai, Shengjie
    Yang, Juan
    Cowling, Benjamin J.
    Horby, Peter W.
    Uyeki, Timothy M.
    Yu, Hongjie
    BMC MEDICINE, 2020, 18 (01)
  • [36] Characterization of the H5N1 Highly Pathogenic Avian Influenza Virus Derived from Wild Pikas in China
    Zhou, Jiyong
    Sun, Wenbo
    Wang, Junhua
    Guo, Junqing
    Yin, Wei
    Wu, Nanping
    Li, Lanjuan
    Yan, Yan
    Liao, Ming
    Huang, Yu
    Luo, Kaijian
    Jiang, Xuetao
    Chen, Hualan
    JOURNAL OF VIROLOGY, 2009, 83 (17) : 8957 - 8964
  • [37] Genetic diversification of H5N1 highly pathogenic avian influenza A virus during replication in wild ducks
    Watanabe, Yohei
    Ibrahim, Madiha S.
    Ellakany, Hany F.
    Abd El-Hamid, Hatem S.
    Ikuta, Kazuyoshi
    JOURNAL OF GENERAL VIROLOGY, 2011, 92 : 2105 - 2110
  • [39] Dairy cows inoculated with highly pathogenic avian influenza virus H5N1
    Baker, Amy L.
    Arruda, Bailey
    Palmer, Mitchell V.
    Boggiatto, Paola
    Davila, Kaitlyn Sarlo
    Buckley, Alexandra
    Zanella, Giovana Ciacci
    Snyder, Celeste A.
    Anderson, Tavis K.
    Hutter, Carl R.
    Nguyen, Thao-Quyen
    Markin, Alexey
    Lantz, Kristina
    Posey, Erin A.
    Torchetti, Mia Kim
    Robbe-Austerman, Suelee
    Magstadt, Drew R.
    Gorden, Patrick J.
    NATURE, 2025, 637 (8047) : 913 - 920
  • [40] Containment of Highly Pathogenic Avian Influenza A(H5N1) Virus, Lebanon, 2016
    Farah, Zeina E.
    Khatib, Omaya
    Hamadeh, Sahar
    Ahmad, Khadija
    El Bazzal, Bassel
    Zalloua, Pierre
    Ammar, Walid
    Ghosn, Nada
    EMERGING INFECTIOUS DISEASES, 2018, 24 (02) : 374 - 376